KRISTEN GUE: Open Payments
NPI 1972960433 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 22 payments from 14 companies in 2025. Trend: 2023 $1,042 · 2024 $1,022 · 2025 $573
Food & beverage: $495Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $95 |
| PFIZER INC. | 4 | $95 |
| ABBVIE INC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $25 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $25 |
| Celgene Corporation | 1 | $23 |
Products named: DARZALEX, IBRANCE, VENCLEXTA, EPKINLY, KEYTRUDA, FRUZAQLA, XTANDI, ZYNLONTA.
Industry payments across GA — which companies pay providers there.
